B-CELL LYMPHOMA REFRACTORY
Clinical trials for B-CELL LYMPHOMA REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOMA REFRACTORY trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOMA REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR T-Cell therapy offers hope for Hard-to-Treat lymphoma
Disease control Recruiting nowThis study tests a personalized cell therapy for people with B-cell lymphoma that has come back or not responded to standard treatments. Participants receive their own immune cells, modified to target cancer cells. The goal is to find the best dose and see if it safely shrinks tu…
Matched conditions: B-CELL LYMPHOMA REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated May 01, 2026 20:12 UTC
-
New hope for hard-to-treat lymphoma in the brain: drug combo trial launches
Disease control Recruiting nowThis study tests a new drug, selinexor, combined with standard chemotherapy for people with B-cell lymphoma that has returned or not responded to treatment and has spread to the brain or spinal cord. The goal is to see if the combination is safe and effective. About 37 adults wil…
Matched conditions: B-CELL LYMPHOMA REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 01, 2026 16:01 UTC